Heilsa Life Sciences Private Limited, a active private limited company, was established on 26 September 2021 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100DL2021PTC387167. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹24.00 Cr and a paid-up capital of ₹16.00 Cr.
It upholds a compliant status. Employing 1 professional, Its leadership includes Yasha Agarwal (Director), Ruchir Gupta (Managing Director), Sumit Kumar Agarwal (Director). Past directors included Ruchir Gupta, Manoj Agarwal, Vijaysing Krupalsing Bhandari. It holds ₹211.25 Cr open charges and ₹147.00 Cr settled loans. Its latest AGM occurred on 12 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No.404/65, Pragati Tower Rajendra Place, Delhi, Delhi, 110008.
U24100DL2021PTC387167
387167
26 September 2021
₹24.00 Cr
₹16.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Heilsa Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yasha Agarwal | Director | 25 Jan 2023 | Current |
| Ruchir Gupta | Managing Director | 26 Sep 2021 | Current |
| Sumit Kumar Agarwal | Director | 26 Sep 2021 | Current |
| Vijaysing Krupalsing Bhandari | Director | 16 Mar 2022 | Current |
| Puneet Kansal | Whole-Time Director | 26 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Sep 2023 | Past |
| Pramod Abcsdd | Director | 01 Jan 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 31 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Heilsa Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 919.66% increase in profit. The company's net worth Soared by an impressive increase of 1410.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Heilsa Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,112,500,000.00
₹1,470,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2023 | Others | ₹147.00 Cr | Open |
| 11 Mar 2022 | Others | ₹64.25 Cr | Open |
| 11 Mar 2022 | Others | ₹147.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Heilsa Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Heilsa Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heilsa Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Heilsa Life Sciences Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records. was documented.
The activity Heilsa Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
A charge with Others of Rs. 64.25 Cr registered on 11 Mar 2022 with Charge ID 100566475 was modified on 18 Dec 2024. was recorded as a recent event.
Progress on A charge with Others of Rs. 147.00 Cr registered on 13 Oct 2023 with Charge ID 100810798 was modified on 16 Dec 2024. was documented.
Progress on A charge registered on 11 Mar 2022 via Charge ID 100566472 with Others was fully satisfied on 03 Nov 2023. was documented.
A charge with Others amounted to Rs. 147.00 Cr with Charge ID 100810798 was registered on 13 Oct 2023. was recorded as a recent event.
The CIN of Heilsa Life Sciences Private Limited is U24100DL2021PTC387167.
Heilsa Life Sciences Private Limited is headquartered at Flat No.404/65, Pragati Tower Rajendra Place, Delhi, Delhi, 110008.
Heilsa Life Sciences Private Limited was incorporated on 26 September 2021.
The current directors of Heilsa Life Sciences Private Limited are
The primary industry of Heilsa Life Sciences Private Limited is Pharma.
Heilsa Life Sciences Private Limited is unlisted.
The authorized capital of Heilsa Life Sciences Private Limited is ₹24.00 Cr, and the paid-up capital is ₹16.00 Cr.
The compliance status of Heilsa Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX